AI assistant
Sending…
Caribou Biosciences, Inc. — Director's Dealing 2021
Nov 8, 2021
33640_dirs_2021-11-08_9f0da43e-08bf-4714-a833-90a33156b4e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Caribou Biosciences, Inc. (CRBU)
CIK: 0001619856
Period of Report: 2021-11-08
Reporting Person: Khan Ruhi Ahmad (Chief Business Officer)
More from Caribou Biosciences, Inc.
Proxy Solicitation & Information Statement
2026
Jun 5
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 20